Cullinan Therapeutics, Inc. CGEM Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$219.88M-31.2% | -$167.58M-8.0% | -$155.1M— | —— | ||
| $311K+1.6% | $306K-1.3% | $310K+233% | $93K+75.5% | ||
| $36.04M-4.7% | $37.82M+24.3% | $30.44M+8.9% | $27.96M+14.7% | ||
| -$175.75M-21.0% | -$145.3M-8.2% | -$134.28M-6.0% | -$126.66M-192% | ||
| —— | $0— | —— | $1.13M— | ||
| $179.99M— | —— | $35.81M— | —— | ||
| $1.09M-99.6% | $266.19M+553% | $40.75M+257% | -$25.93M-110% | ||
| —— | -$15.43M— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Cullinan Therapeutics, Inc. generate?
- Cullinan Therapeutics, Inc. (CGEM) generated -$178.6M in operating cash flow over the trailing twelve months.
- What is Cullinan Therapeutics, Inc.'s free cash flow?
- After $11.0K of capital expenditures, Cullinan Therapeutics, Inc.'s free cash flow was -$145.2M over the trailing twelve months, down 19.4% year over year.
- Where does Cullinan Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Cullinan Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.